Ophthalmology News and Research

RSS

Ophthalmology is the specialized field of medicine that focuses on the health of the eye. It includes the anatomy, physiology and diseases that may affect the eye. Historically, the science of ophthalmology encompassed all aspects of visual function, both in health and in illness. Additionally, ophthalmology also includes animal eyes as ocular function and optic diseases are similar among humans and animals.

Virtual games help blind individuals improve navigation skills and develop cognitive spatial map

JoVE (Journal of Visualized Experiments) will publish a new video article by Dr. Lotfi Merabet showing how researchers in the Department of Ophthalmology at Massachusetts Eye and Ear Infirmary and Harvard Medical School have developed a virtual gaming environment to help blind individuals improve navigation skills and develop a cognitive spatial map of unfamiliar buildings and public locations.

28 Mar 2013

First Edition: March 28, 2013

Today's headlines include various stories about the health law's implementation at both the federal and state level.

28 Mar 2013

New research sheds light on natural mechanism that protects ears from hearing loss

New research from the Massachusetts Eye and Ear, Harvard Medical School and Harvard Program in Speech and Hearing Bioscience and Technology may have discovered a key piece in the puzzle of how hearing works by identifying the role of the olivocochlear efferent system in protecting ears from hearing loss.

28 Mar 2013

Study examines specific form of autism caused by duplication on chromosome 15

Identifying and understanding the combination of factors that leads to autism is an ongoing scientific challenge. This developmental disorder appears in the first three years of life, and affects the brain's normal development of social and communication skills.

27 Mar 2013

Konzo's harm goes beyond devastating physical effects

The harm done by konzo - a disease overshadowed by the war and drought it tends to accompany - goes beyond its devastating physical effects to impair children's memory, problem solving and other cognitive functions.

25 Mar 2013

R-Tech Ueno enrolls retinitis pigmentosa patients in Phase 3 clinical study of UF-021 ophthalmic solution

R-Tech Ueno is pleased to announce the start of the patient enrollment of a Phase 3 clinical study with Unoprostone (development code UF-021) ophthalmic solution that are being developed in our company for the treatment of retinitis pigmentosa.

18 Mar 2013

Eye health can be possible through nutrition and supplements, say experts

Eating healthy can affect more than what the scale says. According to experts at the University of Alabama at Birmingham, it is possible to aid eye health through nutrition and supplements.

16 Mar 2013

Luminex collaborates with Merck to design companion diagnostic device for Alzheimer’s disease

WHITEHOUSE STATION known as MSD outside the United States and Canada, and Luminex Corporation have signed a collaboration and license agreement to develop a companion diagnostic device that will be evaluated to help screen patients for recruitment into Merck's clinical development program for MK-8931, a novel oral beta amyloid precursor protein site cleaving enzyme (BACE) inhibitor and Merck's lead investigational candidate for Alzheimer's disease (AD).

From Luminex 15 Mar 2013

New procedure to treat pseudotumor cerebri

A team of interventional neuroradiologists and neurosurgeons at Johns Hopkins reports wide success with a new procedure to treat pseudotumor cerebri, a rare but potentially blinding condition marked by excessive pressure inside the skull, caused by a dangerous narrowing of a vein located at the base of the brain.

13 Mar 2013

Researchers work on stem cell treatments to halt vision loss caused by diabetic retinopathy

Researchers at the Eugene and Marilyn Glick Eye Institute and the Indiana Center for Vascular Biology at Indiana University School of Medicine are on the cusp of perfecting stem cell treatments that would halt - and potentially reverse - vision loss caused by diabetic retinopathy.

13 Mar 2013

Lithera commences LIPO-202 Phase 2b trial for reduction of subcutaneous fat

Lithera, Inc., a clinical stage pharmaceutical company focused on lifestyle and medical indications in aesthetic medicine and ophthalmology, announced today that the first patient has been treated with LIPO-202 (Salmeterol Xinafoate for Injection) in its 500-patient Phase 2b "RESET" trial.

12 Mar 2013

Peer support groups help combat epilepsy-related stigma

Peer support groups show promise for combating the debilitating stigma that surrounds epilepsy in much of the developing world, according to a new study led by a Michigan State University medical student.

12 Mar 2013

Lack of very long chain fatty acids does not cause blindness in children with Stargardt type 3

Vision scientists long have thought that lack of very long chain fatty acids in photoreceptor cells caused blindness in children with Stargardt type 3 retinal degeneration, an incurable eye disease. But researchers at the University of Utah's John A. Moran Eye Center have shown in a new study that lack of these fatty acids does not cause blindness, meaning that the search for the mechanism that robs sight from children with the disease must start anew.

12 Mar 2013

Reduced visual sensitivity seen with use of multifocal intraocular lenses

Recent study findings indicate that eyes with multifocal intraocular lenses implanted during cataract surgery may develop reduced visual sensitivity.

8 Mar 2013

Antibiotic prophylaxis after IVT may be harmful

Researchers are warning against routine antibiotic prophylaxis with intravitreal injection after finding that the practice can increase the antibiotic resistance of ocular surface flora.

6 Mar 2013

Study shows community-based HIV-prevention efforts increase testing rates, reduce HIV incidence

In Africa and Thailand, communities that worked together on HIV-prevention efforts saw not only a rise in HIV screening but a drop in new infections, according to a new study presented this week at the Conference on Retroviruses and Opportunistic Infections in Atlanta.

6 Mar 2013

Subclinical inflammation predicts macular disease

Levels of high-sensitivity C-reactive protein predict the risk for age-related macular degeneration and diabetic macular edema, show results of two independent studies published in JAMA Ophthalmology.

27 Feb 2013

Global eye health company, Bausch + Lomb, names Robert Bertolini as president and chief financial officer

Bausch + Lomb, the global eye health company, has named Robert Bertolini as president and chief financial officer effective immediately. In this capacity, he will oversee the company's Finance, Information Technology and Global Quality and Operations (GQO) functions. Bertolini, who assumes CFO responsibilities from Brian J. Harris, will report to Bausch + Lomb's chief executive officer, Brent Saunders.

27 Feb 2013

Ampio Pharmaceuticals starts Optina clinical trial

Ampio Pharmaceuticals, Inc. announced oral dosing of the first patient in a 505(b)(2) clinical trial of the investigational drug Optina in diabetic macular edema.

27 Feb 2013

Vision CRC develops retinal camera for detection of blinding eye disease and general health disorders

The most advanced technology for use in real-time detection and assessment of common blinding eye disease and general health disorders will soon be available to the world with stimulus funding provided for development by the Australian Government's CRC Program.

27 Feb 2013

Ophthalmology News and Research

Further Reading

Virtual games help blind individuals improve navigation skills and develop cognitive spatial map

First Edition: March 28, 2013

New research sheds light on natural mechanism that protects ears from hearing loss

Study examines specific form of autism caused by duplication on chromosome 15

Konzo's harm goes beyond devastating physical effects

R-Tech Ueno enrolls retinitis pigmentosa patients in Phase 3 clinical study of UF-021 ophthalmic solution

Eye health can be possible through nutrition and supplements, say experts

Luminex collaborates with Merck to design companion diagnostic device for Alzheimer’s disease

New procedure to treat pseudotumor cerebri

Researchers work on stem cell treatments to halt vision loss caused by diabetic retinopathy

Lithera commences LIPO-202 Phase 2b trial for reduction of subcutaneous fat

Peer support groups help combat epilepsy-related stigma

Lack of very long chain fatty acids does not cause blindness in children with Stargardt type 3

Reduced visual sensitivity seen with use of multifocal intraocular lenses

Antibiotic prophylaxis after IVT may be harmful

Study shows community-based HIV-prevention efforts increase testing rates, reduce HIV incidence

Subclinical inflammation predicts macular disease

Global eye health company, Bausch + Lomb, names Robert Bertolini as president and chief financial officer

Ampio Pharmaceuticals starts Optina clinical trial

Vision CRC develops retinal camera for detection of blinding eye disease and general health disorders

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News